Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
160.40 | -20.17% | -9.62% | 283,245.19 | 3.86% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
312.86 | -12.37% | -3.59% | 167,828.96 | 2.93% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
64.58 | 26.78% | 36.48% | 80,529.28 | 4.74% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
222.75 | -12.25% | 3.32% | 32,431.71 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
81.72 | 140.15% | 218.9% | 15,516.98 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
53.50 | 104.78% | 153.24% | 12,015.18 | 0% | 27.62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
80.20 | 0% | 0% | 8,811.53 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
108.34 | 0% | 0% | 6,811.47 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
13.45 | 0% | 0% | 3,746.95 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
24.72 | 0% | 0% | 3,062.73 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
9.48 | 0% | 0% | 2,807.75 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
15.21 | 0% | 0% | 2,829.94 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
41.06 | 0% | 0% | 2,805.15 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
48.65 | -94.78% | -76.15% | 2,364.47 | 0% | 0% |
|
NasdaqGM:ARDX
Ardelyx
|
8.06 | 0% | 0% | 2,040.28 | 0% | 0% |
